je.st
news
Ksa Capital Management Purchases Shares of 55,000 SPDR S&P Biotech
2015-12-20 01:38:05| Biotech - Topix.net
KSA Capital Management purchased a new position in SPDR S&P Biotech during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The hedge fund purchased 55,000 shares of the company's stock, valued at approximately $3,423,000.
Tags: management
capital
shares
purchases
Category:Biotechnology and Pharmaceuticals